nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—melanoma	0.525	1	CbGaD
Pioglitazone—SLCO1B3—Docetaxel—melanoma	0.112	0.42	CbGbCtD
Pioglitazone—CYP3A4—Temozolomide—melanoma	0.0596	0.223	CbGbCtD
Pioglitazone—CYP2D6—Vemurafenib—melanoma	0.0514	0.192	CbGbCtD
Pioglitazone—CYP3A4—Vemurafenib—melanoma	0.0327	0.122	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—melanoma	0.0112	0.042	CbGbCtD
Pioglitazone—PPARG—dermis—melanoma	0.0065	0.222	CbGeAlD
Pioglitazone—PPARG—leg—melanoma	0.00429	0.147	CbGeAlD
Pioglitazone—PPARG—hindlimb—melanoma	0.00383	0.131	CbGeAlD
Pioglitazone—PPARG—appendage—melanoma	0.00329	0.112	CbGeAlD
Pioglitazone—Polyp—Vemurafenib—melanoma	0.0031	0.0272	CcSEcCtD
Pioglitazone—Cyst—Vemurafenib—melanoma	0.00282	0.0248	CcSEcCtD
Pioglitazone—Rosiglitazone—PPARG—melanoma	0.00214	0.727	CrCbGaD
Pioglitazone—PPARG—endothelium—melanoma	0.00199	0.0678	CbGeAlD
Pioglitazone—Transient ischaemic attack—Temozolomide—melanoma	0.00191	0.0168	CcSEcCtD
Pioglitazone—PPARG—blood vessel—melanoma	0.00183	0.0626	CbGeAlD
Pioglitazone—Neoplasm—Vemurafenib—melanoma	0.0017	0.015	CcSEcCtD
Pioglitazone—Visual acuity reduced—Temozolomide—melanoma	0.00162	0.0142	CcSEcCtD
Pioglitazone—Cyst—Carmustine—melanoma	0.00149	0.0131	CcSEcCtD
Pioglitazone—Tooth disorder—Temozolomide—melanoma	0.00149	0.013	CcSEcCtD
Pioglitazone—Pain in extremity—Vemurafenib—melanoma	0.00137	0.012	CcSEcCtD
Pioglitazone—PPARG—neck—melanoma	0.00131	0.0448	CbGeAlD
Pioglitazone—Accidental injury—Carmustine—melanoma	0.00113	0.0099	CcSEcCtD
Pioglitazone—Weight decreased—Vemurafenib—melanoma	0.00107	0.0094	CcSEcCtD
Pioglitazone—PTGS1—endothelium—melanoma	0.00106	0.0363	CbGeAlD
Pioglitazone—Infestation NOS—Vemurafenib—melanoma	0.00105	0.00926	CcSEcCtD
Pioglitazone—Infestation—Vemurafenib—melanoma	0.00105	0.00926	CcSEcCtD
Pioglitazone—Polyp—Docetaxel—melanoma	0.00105	0.00925	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Temozolomide—melanoma	0.00102	0.00895	CcSEcCtD
Pioglitazone—PTGS1—blood vessel—melanoma	0.000979	0.0334	CbGeAlD
Pioglitazone—Cyst—Docetaxel—melanoma	0.000958	0.00842	CcSEcCtD
Pioglitazone—Liver disorder—Docetaxel—melanoma	0.00094	0.00826	CcSEcCtD
Pioglitazone—Oedema peripheral—Vemurafenib—melanoma	0.000932	0.00819	CcSEcCtD
Pioglitazone—Connective tissue disorder—Vemurafenib—melanoma	0.00093	0.00817	CcSEcCtD
Pioglitazone—Injury—Bleomycin—melanoma	0.000902	0.00792	CcSEcCtD
Pioglitazone—Neoplasm—Carmustine—melanoma	0.000901	0.00792	CcSEcCtD
Pioglitazone—Eye disorder—Vemurafenib—melanoma	0.000885	0.00777	CcSEcCtD
Pioglitazone—Cardiac disorder—Vemurafenib—melanoma	0.000878	0.00772	CcSEcCtD
Pioglitazone—Neoplasm—Temozolomide—melanoma	0.000871	0.00765	CcSEcCtD
Pioglitazone—Abnormal vision—Carmustine—melanoma	0.000869	0.00764	CcSEcCtD
Pioglitazone—Hepatic failure—Dactinomycin—melanoma	0.00086	0.00756	CcSEcCtD
Pioglitazone—Mediastinal disorder—Vemurafenib—melanoma	0.000853	0.0075	CcSEcCtD
Pioglitazone—PPARG—skin of body—melanoma	0.000848	0.029	CbGeAlD
Pioglitazone—Cerebrovascular accident—Bleomycin—melanoma	0.000846	0.00743	CcSEcCtD
Pioglitazone—Abnormal vision—Temozolomide—melanoma	0.00084	0.00738	CcSEcCtD
Pioglitazone—Diabetes mellitus—Carmustine—melanoma	0.000832	0.00731	CcSEcCtD
Pioglitazone—Malnutrition—Vemurafenib—melanoma	0.000824	0.00724	CcSEcCtD
Pioglitazone—Rosiglitazone—ALB—melanoma	0.000805	0.273	CrCbGaD
Pioglitazone—Back pain—Vemurafenib—melanoma	0.000797	0.007	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Docetaxel—melanoma	0.000797	0.007	CcSEcCtD
Pioglitazone—Gastroenteritis—Temozolomide—melanoma	0.000789	0.00693	CcSEcCtD
Pioglitazone—Injury—Carmustine—melanoma	0.000787	0.00692	CcSEcCtD
Pioglitazone—Hepatic failure—Temozolomide—melanoma	0.000778	0.00684	CcSEcCtD
Pioglitazone—PPARG—mammalian vulva—melanoma	0.000773	0.0264	CbGeAlD
Pioglitazone—Liver function test abnormal—Dactinomycin—melanoma	0.000714	0.00627	CcSEcCtD
Pioglitazone—Myalgia—Vemurafenib—melanoma	0.000701	0.00616	CcSEcCtD
Pioglitazone—Arthralgia—Vemurafenib—melanoma	0.000701	0.00616	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000697	0.00612	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vemurafenib—melanoma	0.000672	0.00591	CcSEcCtD
Pioglitazone—Infection—Vemurafenib—melanoma	0.000668	0.00587	CcSEcCtD
Pioglitazone—Liver function test abnormal—Carmustine—melanoma	0.000668	0.00587	CcSEcCtD
Pioglitazone—Nervous system disorder—Vemurafenib—melanoma	0.000659	0.00579	CcSEcCtD
Pioglitazone—Skin disorder—Vemurafenib—melanoma	0.000653	0.00574	CcSEcCtD
Pioglitazone—Weight decreased—Bleomycin—melanoma	0.000648	0.0057	CcSEcCtD
Pioglitazone—Breast disorder—Temozolomide—melanoma	0.000632	0.00555	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Bleomycin—melanoma	0.00063	0.00553	CcSEcCtD
Pioglitazone—Myocardial infarction—Bleomycin—melanoma	0.000626	0.0055	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Temozolomide—melanoma	0.000617	0.00542	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000613	0.00538	CcSEcCtD
Pioglitazone—Haematuria—Bleomycin—melanoma	0.000609	0.00535	CcSEcCtD
Pioglitazone—Fluid retention—Docetaxel—melanoma	0.000608	0.00534	CcSEcCtD
Pioglitazone—Bronchitis—Temozolomide—melanoma	0.000581	0.00511	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000581	0.0051	CcSEcCtD
Pioglitazone—Fatigue—Vemurafenib—melanoma	0.00058	0.00509	CcSEcCtD
Pioglitazone—Neoplasm—Docetaxel—melanoma	0.000579	0.00509	CcSEcCtD
Pioglitazone—Hypoaesthesia—Bleomycin—melanoma	0.000571	0.00501	CcSEcCtD
Pioglitazone—Pulmonary oedema—Docetaxel—melanoma	0.00057	0.00501	CcSEcCtD
Pioglitazone—Hyperglycaemia—Carmustine—melanoma	0.000564	0.00496	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Temozolomide—melanoma	0.000562	0.00494	CcSEcCtD
Pioglitazone—Erectile dysfunction—Temozolomide—melanoma	0.000557	0.00489	CcSEcCtD
Pioglitazone—PPARG—head—melanoma	0.000553	0.0189	CbGeAlD
Pioglitazone—Weight increased—Temozolomide—melanoma	0.00055	0.00483	CcSEcCtD
Pioglitazone—Weight decreased—Temozolomide—melanoma	0.000547	0.0048	CcSEcCtD
Pioglitazone—Hyperglycaemia—Temozolomide—melanoma	0.000545	0.00479	CcSEcCtD
Pioglitazone—Urinary tract infection—Carmustine—melanoma	0.000542	0.00476	CcSEcCtD
Pioglitazone—Infestation NOS—Temozolomide—melanoma	0.000539	0.00473	CcSEcCtD
Pioglitazone—Infestation—Temozolomide—melanoma	0.000539	0.00473	CcSEcCtD
Pioglitazone—Hepatitis—Dactinomycin—melanoma	0.000535	0.0047	CcSEcCtD
Pioglitazone—Pharyngitis—Dactinomycin—melanoma	0.000531	0.00466	CcSEcCtD
Pioglitazone—Urinary tract infection—Temozolomide—melanoma	0.000524	0.0046	CcSEcCtD
Pioglitazone—Hepatic failure—Docetaxel—melanoma	0.000517	0.00455	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Docetaxel—melanoma	0.000513	0.00451	CcSEcCtD
Pioglitazone—Sinusitis—Temozolomide—melanoma	0.000506	0.00444	CcSEcCtD
Pioglitazone—Hypoaesthesia—Carmustine—melanoma	0.000498	0.00438	CcSEcCtD
Pioglitazone—Hypersensitivity—Vemurafenib—melanoma	0.000495	0.00435	CcSEcCtD
Pioglitazone—Oedema peripheral—Carmustine—melanoma	0.000493	0.00433	CcSEcCtD
Pioglitazone—Connective tissue disorder—Carmustine—melanoma	0.000492	0.00432	CcSEcCtD
Pioglitazone—Visual disturbance—Docetaxel—melanoma	0.000491	0.00431	CcSEcCtD
Pioglitazone—Hepatitis—Temozolomide—melanoma	0.000484	0.00425	CcSEcCtD
Pioglitazone—Asthenia—Vemurafenib—melanoma	0.000482	0.00424	CcSEcCtD
Pioglitazone—Visual impairment—Carmustine—melanoma	0.000482	0.00424	CcSEcCtD
Pioglitazone—Hypoaesthesia—Temozolomide—melanoma	0.000481	0.00423	CcSEcCtD
Pioglitazone—Pharyngitis—Temozolomide—melanoma	0.00048	0.00422	CcSEcCtD
Pioglitazone—Urinary tract disorder—Temozolomide—melanoma	0.000478	0.0042	CcSEcCtD
Pioglitazone—Oedema peripheral—Temozolomide—melanoma	0.000477	0.00419	CcSEcCtD
Pioglitazone—Cardiac failure—Docetaxel—melanoma	0.000476	0.00419	CcSEcCtD
Pioglitazone—Connective tissue disorder—Temozolomide—melanoma	0.000475	0.00418	CcSEcCtD
Pioglitazone—Urethral disorder—Temozolomide—melanoma	0.000474	0.00417	CcSEcCtD
Pioglitazone—Eye disorder—Carmustine—melanoma	0.000468	0.00411	CcSEcCtD
Pioglitazone—Visual impairment—Temozolomide—melanoma	0.000466	0.0041	CcSEcCtD
Pioglitazone—Pain in extremity—Docetaxel—melanoma	0.000465	0.00409	CcSEcCtD
Pioglitazone—Ill-defined disorder—Bleomycin—melanoma	0.000463	0.00407	CcSEcCtD
Pioglitazone—Anaemia—Bleomycin—melanoma	0.000461	0.00405	CcSEcCtD
Pioglitazone—Diarrhoea—Vemurafenib—melanoma	0.00046	0.00404	CcSEcCtD
Pioglitazone—PTGS1—skin of body—melanoma	0.000453	0.0155	CbGeAlD
Pioglitazone—Eye disorder—Temozolomide—melanoma	0.000452	0.00397	CcSEcCtD
Pioglitazone—Malaise—Bleomycin—melanoma	0.00045	0.00396	CcSEcCtD
Pioglitazone—Cardiac disorder—Temozolomide—melanoma	0.000449	0.00394	CcSEcCtD
Pioglitazone—Dizziness—Vemurafenib—melanoma	0.000445	0.00391	CcSEcCtD
Pioglitazone—Immune system disorder—Temozolomide—melanoma	0.000437	0.00384	CcSEcCtD
Pioglitazone—Mediastinal disorder—Temozolomide—melanoma	0.000436	0.00383	CcSEcCtD
Pioglitazone—Malnutrition—Carmustine—melanoma	0.000436	0.00383	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dactinomycin—melanoma	0.000432	0.0038	CcSEcCtD
Pioglitazone—Anaemia—Dactinomycin—melanoma	0.00043	0.00378	CcSEcCtD
Pioglitazone—Liver function test abnormal—Docetaxel—melanoma	0.000429	0.00377	CcSEcCtD
Pioglitazone—Chest pain—Bleomycin—melanoma	0.000425	0.00373	CcSEcCtD
Pioglitazone—Myalgia—Bleomycin—melanoma	0.000425	0.00373	CcSEcCtD
Pioglitazone—Abdominal pain upper—Docetaxel—melanoma	0.000425	0.00373	CcSEcCtD
Pioglitazone—Back pain—Carmustine—melanoma	0.000421	0.0037	CcSEcCtD
Pioglitazone—Headache—Vemurafenib—melanoma	0.000421	0.0037	CcSEcCtD
Pioglitazone—Malnutrition—Temozolomide—melanoma	0.000421	0.0037	CcSEcCtD
Pioglitazone—Breast disorder—Docetaxel—melanoma	0.00042	0.00369	CcSEcCtD
Pioglitazone—Discomfort—Bleomycin—melanoma	0.00042	0.00369	CcSEcCtD
Pioglitazone—Malaise—Dactinomycin—melanoma	0.00042	0.00369	CcSEcCtD
Pioglitazone—PTGS1—mammalian vulva—melanoma	0.000413	0.0141	CbGeAlD
Pioglitazone—Alanine aminotransferase increased—Docetaxel—melanoma	0.00041	0.0036	CcSEcCtD
Pioglitazone—Anaphylactic shock—Bleomycin—melanoma	0.000407	0.00358	CcSEcCtD
Pioglitazone—Oedema—Bleomycin—melanoma	0.000407	0.00358	CcSEcCtD
Pioglitazone—Back pain—Temozolomide—melanoma	0.000407	0.00358	CcSEcCtD
Pioglitazone—Infection—Bleomycin—melanoma	0.000405	0.00356	CcSEcCtD
Pioglitazone—Anaemia—Carmustine—melanoma	0.000403	0.00354	CcSEcCtD
Pioglitazone—Myalgia—Dactinomycin—melanoma	0.000396	0.00348	CcSEcCtD
Pioglitazone—Discomfort—Dactinomycin—melanoma	0.000392	0.00344	CcSEcCtD
Pioglitazone—Angina pectoris—Docetaxel—melanoma	0.000391	0.00344	CcSEcCtD
Pioglitazone—Ill-defined disorder—Temozolomide—melanoma	0.000391	0.00343	CcSEcCtD
Pioglitazone—Anaemia—Temozolomide—melanoma	0.000389	0.00342	CcSEcCtD
Pioglitazone—PPARG—lymph node—melanoma	0.000387	0.0132	CbGeAlD
Pioglitazone—Angioedema—Temozolomide—melanoma	0.000385	0.00338	CcSEcCtD
Pioglitazone—Oedema—Dactinomycin—melanoma	0.00038	0.00334	CcSEcCtD
Pioglitazone—Malaise—Temozolomide—melanoma	0.00038	0.00334	CcSEcCtD
Pioglitazone—Vertigo—Temozolomide—melanoma	0.000378	0.00332	CcSEcCtD
Pioglitazone—Infection—Dactinomycin—melanoma	0.000377	0.00332	CcSEcCtD
Pioglitazone—Hypertension—Carmustine—melanoma	0.000376	0.00331	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000371	0.00326	CcSEcCtD
Pioglitazone—Myalgia—Carmustine—melanoma	0.000371	0.00326	CcSEcCtD
Pioglitazone—Chest pain—Carmustine—melanoma	0.000371	0.00326	CcSEcCtD
Pioglitazone—Weight increased—Docetaxel—melanoma	0.000366	0.00321	CcSEcCtD
Pioglitazone—Weight decreased—Docetaxel—melanoma	0.000364	0.00319	CcSEcCtD
Pioglitazone—Hypertension—Temozolomide—melanoma	0.000364	0.00319	CcSEcCtD
Pioglitazone—Dyspnoea—Bleomycin—melanoma	0.000363	0.00319	CcSEcCtD
Pioglitazone—Arthralgia—Temozolomide—melanoma	0.000358	0.00315	CcSEcCtD
Pioglitazone—Myalgia—Temozolomide—melanoma	0.000358	0.00315	CcSEcCtD
Pioglitazone—Infestation NOS—Docetaxel—melanoma	0.000358	0.00315	CcSEcCtD
Pioglitazone—Infestation—Docetaxel—melanoma	0.000358	0.00315	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000356	0.00313	CcSEcCtD
Pioglitazone—Oedema—Carmustine—melanoma	0.000356	0.00312	CcSEcCtD
Pioglitazone—Discomfort—Temozolomide—melanoma	0.000354	0.00311	CcSEcCtD
Pioglitazone—Infection—Carmustine—melanoma	0.000353	0.0031	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Docetaxel—melanoma	0.000353	0.0031	CcSEcCtD
Pioglitazone—Myocardial infarction—Docetaxel—melanoma	0.000351	0.00309	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000346	0.00304	CcSEcCtD
Pioglitazone—Anaphylactic shock—Temozolomide—melanoma	0.000344	0.00302	CcSEcCtD
Pioglitazone—Oedema—Temozolomide—melanoma	0.000344	0.00302	CcSEcCtD
Pioglitazone—Infection—Temozolomide—melanoma	0.000341	0.003	CcSEcCtD
Pioglitazone—Nervous system disorder—Temozolomide—melanoma	0.000337	0.00296	CcSEcCtD
Pioglitazone—Feeling abnormal—Bleomycin—melanoma	0.000336	0.00295	CcSEcCtD
Pioglitazone—Skin disorder—Temozolomide—melanoma	0.000334	0.00293	CcSEcCtD
Pioglitazone—Hyperhidrosis—Temozolomide—melanoma	0.000332	0.00292	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—melanoma	0.000328	0.00288	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Carmustine—melanoma	0.000324	0.00285	CcSEcCtD
Pioglitazone—Urticaria—Bleomycin—melanoma	0.000324	0.00284	CcSEcCtD
Pioglitazone—Hepatitis—Docetaxel—melanoma	0.000322	0.00283	CcSEcCtD
Pioglitazone—Insomnia—Carmustine—melanoma	0.000322	0.00283	CcSEcCtD
Pioglitazone—Hypoaesthesia—Docetaxel—melanoma	0.00032	0.00281	CcSEcCtD
Pioglitazone—Pharyngitis—Docetaxel—melanoma	0.000319	0.00281	CcSEcCtD
Pioglitazone—Urinary tract disorder—Docetaxel—melanoma	0.000318	0.00279	CcSEcCtD
Pioglitazone—Dyspnoea—Carmustine—melanoma	0.000317	0.00279	CcSEcCtD
Pioglitazone—Oedema peripheral—Docetaxel—melanoma	0.000317	0.00278	CcSEcCtD
Pioglitazone—Connective tissue disorder—Docetaxel—melanoma	0.000316	0.00278	CcSEcCtD
Pioglitazone—Urethral disorder—Docetaxel—melanoma	0.000315	0.00277	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—melanoma	0.000313	0.00275	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000313	0.00275	CcSEcCtD
Pioglitazone—Insomnia—Temozolomide—melanoma	0.000311	0.00273	CcSEcCtD
Pioglitazone—Visual impairment—Docetaxel—melanoma	0.00031	0.00272	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Carmustine—melanoma	0.000307	0.0027	CcSEcCtD
Pioglitazone—Dyspnoea—Temozolomide—melanoma	0.000306	0.00269	CcSEcCtD
Pioglitazone—Eye disorder—Docetaxel—melanoma	0.000301	0.00264	CcSEcCtD
Pioglitazone—Hypersensitivity—Bleomycin—melanoma	0.0003	0.00264	CcSEcCtD
Pioglitazone—Cardiac disorder—Docetaxel—melanoma	0.000299	0.00262	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Temozolomide—melanoma	0.000297	0.00261	CcSEcCtD
Pioglitazone—Fatigue—Temozolomide—melanoma	0.000296	0.0026	CcSEcCtD
Pioglitazone—PTGS1—head—melanoma	0.000296	0.0101	CbGeAlD
Pioglitazone—Feeling abnormal—Carmustine—melanoma	0.000293	0.00258	CcSEcCtD
Pioglitazone—Asthenia—Bleomycin—melanoma	0.000292	0.00257	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—melanoma	0.000291	0.00255	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—melanoma	0.00029	0.00255	CcSEcCtD
Pioglitazone—Feeling abnormal—Temozolomide—melanoma	0.000283	0.00249	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—melanoma	0.00028	0.00246	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—melanoma	0.00028	0.00246	CcSEcCtD
Pioglitazone—Urticaria—Temozolomide—melanoma	0.000273	0.0024	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—melanoma	0.000273	0.0024	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—melanoma	0.000271	0.00238	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—melanoma	0.000269	0.00237	CcSEcCtD
Pioglitazone—Hypersensitivity—Carmustine—melanoma	0.000262	0.0023	CcSEcCtD
Pioglitazone—Diarrhoea—Dactinomycin—melanoma	0.00026	0.00228	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—melanoma	0.000259	0.00227	CcSEcCtD
Pioglitazone—Asthenia—Carmustine—melanoma	0.000255	0.00224	CcSEcCtD
Pioglitazone—Hypersensitivity—Temozolomide—melanoma	0.000253	0.00222	CcSEcCtD
Pioglitazone—Asthenia—Temozolomide—melanoma	0.000247	0.00217	CcSEcCtD
Pioglitazone—Diarrhoea—Carmustine—melanoma	0.000243	0.00214	CcSEcCtD
Pioglitazone—CYP2D6—head—melanoma	0.000243	0.0083	CbGeAlD
Pioglitazone—Hypertension—Docetaxel—melanoma	0.000242	0.00212	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—melanoma	0.000238	0.00209	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—melanoma	0.000238	0.00209	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—melanoma	0.000238	0.00209	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000237	0.00208	CcSEcCtD
Pioglitazone—Dizziness—Carmustine—melanoma	0.000235	0.00207	CcSEcCtD
Pioglitazone—Diarrhoea—Temozolomide—melanoma	0.000235	0.00207	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—melanoma	0.000229	0.00201	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—melanoma	0.000229	0.00201	CcSEcCtD
Pioglitazone—Dizziness—Temozolomide—melanoma	0.000227	0.002	CcSEcCtD
Pioglitazone—Infection—Docetaxel—melanoma	0.000227	0.002	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—melanoma	0.000224	0.00197	CcSEcCtD
Pioglitazone—Headache—Carmustine—melanoma	0.000223	0.00196	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—melanoma	0.000222	0.00195	CcSEcCtD
Pioglitazone—Headache—Temozolomide—melanoma	0.000215	0.00189	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000208	0.00183	CcSEcCtD
Pioglitazone—PTGS1—lymph node—melanoma	0.000207	0.00708	CbGeAlD
Pioglitazone—Insomnia—Docetaxel—melanoma	0.000207	0.00182	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—melanoma	0.000204	0.00179	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—melanoma	0.000197	0.00173	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—melanoma	0.000197	0.00173	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—melanoma	0.000188	0.00165	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—melanoma	0.000168	0.00148	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—melanoma	0.000164	0.00144	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—melanoma	0.000156	0.00137	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—melanoma	0.000151	0.00133	CcSEcCtD
Pioglitazone—Headache—Docetaxel—melanoma	0.000143	0.00126	CcSEcCtD
Pioglitazone—CYP2C8—Metabolism—CSPG4—melanoma	1.74e-05	0.000279	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTAP—melanoma	1.72e-05	0.000277	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC5A5—melanoma	1.72e-05	0.000276	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTAP—melanoma	1.71e-05	0.000274	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK3—melanoma	1.71e-05	0.000274	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPAM—melanoma	1.69e-05	0.00027	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP17A1—melanoma	1.68e-05	0.00027	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LUM—melanoma	1.67e-05	0.000268	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PHGDH—melanoma	1.67e-05	0.000268	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.67e-05	0.000268	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ABCB1—melanoma	1.66e-05	0.000267	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GNAQ—melanoma	1.66e-05	0.000266	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CD44—melanoma	1.66e-05	0.000266	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.66e-05	0.000266	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HPSE—melanoma	1.64e-05	0.000263	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.64e-05	0.000263	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HS3ST5—melanoma	1.63e-05	0.000261	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.62e-05	0.000261	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK1—melanoma	1.62e-05	0.00026	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EGFR—melanoma	1.62e-05	0.00026	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.61e-05	0.000258	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CUBN—melanoma	1.61e-05	0.000258	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1B1—melanoma	1.59e-05	0.000255	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GNA11—melanoma	1.59e-05	0.000255	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NOTCH1—melanoma	1.58e-05	0.000253	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—FASN—melanoma	1.55e-05	0.000249	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SDHD—melanoma	1.55e-05	0.000249	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CSPG4—melanoma	1.55e-05	0.000249	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BSG—melanoma	1.55e-05	0.000249	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—melanoma	1.55e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LUM—melanoma	1.54e-05	0.000247	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PHGDH—melanoma	1.54e-05	0.000247	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—melanoma	1.53e-05	0.000246	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PRKCA—melanoma	1.53e-05	0.000246	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC5A5—melanoma	1.53e-05	0.000245	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PHGDH—melanoma	1.52e-05	0.000244	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LUM—melanoma	1.52e-05	0.000244	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ERCC2—melanoma	1.52e-05	0.000244	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HPSE—melanoma	1.51e-05	0.000242	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPAM—melanoma	1.5e-05	0.000241	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HPSE—melanoma	1.49e-05	0.00024	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CUBN—melanoma	1.48e-05	0.000237	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GNAQ—melanoma	1.48e-05	0.000237	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CD44—melanoma	1.48e-05	0.000237	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-05	0.000237	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CUBN—melanoma	1.47e-05	0.000235	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.45e-05	0.000232	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLA2G6—melanoma	1.43e-05	0.00023	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.43e-05	0.00023	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SDHD—melanoma	1.43e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BSG—melanoma	1.43e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CSPG4—melanoma	1.43e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SDHD—melanoma	1.42e-05	0.000227	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BSG—melanoma	1.42e-05	0.000227	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CSPG4—melanoma	1.42e-05	0.000227	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1B1—melanoma	1.42e-05	0.000227	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CG—melanoma	1.41e-05	0.000226	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.4e-05	0.000225	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPAM—melanoma	1.38e-05	0.000222	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPAM—melanoma	1.37e-05	0.00022	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPARG—melanoma	1.36e-05	0.000218	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ABCB1—melanoma	1.31e-05	0.00021	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—melanoma	1.3e-05	0.000209	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—VCAN—melanoma	1.29e-05	0.000207	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLA2G6—melanoma	1.28e-05	0.000205	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.26e-05	0.000202	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.25e-05	0.0002	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—melanoma	1.25e-05	0.0002	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CD—melanoma	1.24e-05	0.000198	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLCB4—melanoma	1.23e-05	0.000198	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—melanoma	1.22e-05	0.000196	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.22e-05	0.000195	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PRKCA—melanoma	1.21e-05	0.000193	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CG—melanoma	1.2e-05	0.000192	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ERCC2—melanoma	1.2e-05	0.000192	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLA2G6—melanoma	1.18e-05	0.000189	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.18e-05	0.000189	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLA2G6—melanoma	1.17e-05	0.000187	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—melanoma	1.17e-05	0.000187	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC6A11—melanoma	1.16e-05	0.000186	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.16e-05	0.000186	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—melanoma	1.15e-05	0.000185	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—VCAN—melanoma	1.15e-05	0.000184	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTAP—melanoma	1.13e-05	0.000181	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.09e-05	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP17A1—melanoma	1.09e-05	0.000174	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CB—melanoma	1.08e-05	0.000173	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PRKCA—melanoma	1.07e-05	0.000172	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.07e-05	0.000172	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—melanoma	1.07e-05	0.000171	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ERCC2—melanoma	1.06e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.06e-05	0.00017	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—VCAN—melanoma	1.06e-05	0.00017	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CD—melanoma	1.05e-05	0.000169	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.05e-05	0.000168	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—VCAN—melanoma	1.05e-05	0.000168	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—melanoma	1.04e-05	0.000167	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GNA11—melanoma	1.03e-05	0.000165	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LUM—melanoma	1e-05	0.000161	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PHGDH—melanoma	1e-05	0.000161	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—FASN—melanoma	1e-05	0.000161	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.92e-06	0.000159	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.91e-06	0.000159	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A5—melanoma	9.87e-06	0.000158	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPSE—melanoma	9.85e-06	0.000158	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP17A1—melanoma	9.69e-06	0.000156	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CUBN—melanoma	9.67e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.57e-06	0.000154	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.56e-06	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GNAQ—melanoma	9.54e-06	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CD44—melanoma	9.54e-06	0.000153	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—melanoma	9.44e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.44e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SDHD—melanoma	9.34e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CSPG4—melanoma	9.34e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BSG—melanoma	9.34e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.34e-06	0.00015	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—melanoma	9.31e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.25e-06	0.000148	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—melanoma	9.19e-06	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GNA11—melanoma	9.16e-06	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1B1—melanoma	9.14e-06	0.000147	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—melanoma	9.12e-06	0.000146	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—melanoma	9.11e-06	0.000146	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPAM—melanoma	9.05e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FASN—melanoma	8.96e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP17A1—melanoma	8.92e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP17A1—melanoma	8.84e-06	0.000142	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—melanoma	8.81e-06	0.000141	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.81e-06	0.000141	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—melanoma	8.73e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.72e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.61e-06	0.000138	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GNAQ—melanoma	8.51e-06	0.000137	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CD44—melanoma	8.51e-06	0.000137	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—melanoma	8.49e-06	0.000136	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GNA11—melanoma	8.42e-06	0.000135	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—melanoma	8.4e-06	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GNA11—melanoma	8.35e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.33e-06	0.000134	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—melanoma	8.3e-06	0.000133	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.26e-06	0.000132	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FASN—melanoma	8.24e-06	0.000132	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—melanoma	8.2e-06	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FASN—melanoma	8.17e-06	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1B1—melanoma	8.16e-06	0.000131	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—melanoma	8.11e-06	0.00013	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—melanoma	8.11e-06	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.07e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—melanoma	8.04e-06	0.000129	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—melanoma	7.94e-06	0.000127	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GNAQ—melanoma	7.83e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CD44—melanoma	7.83e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GNAQ—melanoma	7.76e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CD44—melanoma	7.76e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G6—melanoma	7.69e-06	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.6e-06	0.000122	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.53e-06	0.000121	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—melanoma	7.53e-06	0.000121	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1B1—melanoma	7.51e-06	0.00012	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1B1—melanoma	7.44e-06	0.000119	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—melanoma	7.39e-06	0.000118	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—melanoma	7.29e-06	0.000117	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—melanoma	7.24e-06	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.2e-06	0.000116	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—melanoma	7.17e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PRKCA—melanoma	6.93e-06	0.000111	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—VCAN—melanoma	6.91e-06	0.000111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ERCC2—melanoma	6.87e-06	0.00011	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—melanoma	6.72e-06	0.000108	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.57e-06	0.000105	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—melanoma	6.57e-06	0.000105	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—melanoma	6.44e-06	0.000103	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—melanoma	6.38e-06	0.000102	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—melanoma	6.25e-06	0.0001	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PRKCA—melanoma	6.18e-06	9.92e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—melanoma	6.18e-06	9.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ERCC2—melanoma	6.13e-06	9.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—melanoma	6.13e-06	9.83e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—melanoma	5.89e-06	9.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP17A1—melanoma	5.83e-06	9.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.69e-06	9.13e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PRKCA—melanoma	5.69e-06	9.12e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ERCC2—melanoma	5.64e-06	9.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PRKCA—melanoma	5.64e-06	9.05e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—melanoma	5.6e-06	8.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ERCC2—melanoma	5.59e-06	8.97e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—melanoma	5.56e-06	8.92e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNA11—melanoma	5.51e-06	8.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—melanoma	5.43e-06	8.71e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FASN—melanoma	5.39e-06	8.64e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—melanoma	5.36e-06	8.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—melanoma	5.3e-06	8.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—melanoma	5.24e-06	8.4e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CD44—melanoma	5.12e-06	8.21e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNAQ—melanoma	5.12e-06	8.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.08e-06	8.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1B1—melanoma	4.91e-06	7.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—melanoma	4.84e-06	7.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—melanoma	4.77e-06	7.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—melanoma	4.71e-06	7.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—melanoma	4.68e-06	7.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.63e-06	7.43e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—melanoma	4.58e-06	7.34e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—melanoma	4.46e-06	7.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—melanoma	4.42e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—melanoma	4.41e-06	7.08e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—melanoma	4.3e-06	6.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—melanoma	4.26e-06	6.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—melanoma	4.26e-06	6.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—melanoma	4.2e-06	6.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—melanoma	4.16e-06	6.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—melanoma	4.12e-06	6.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—melanoma	4.04e-06	6.48e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—melanoma	3.92e-06	6.3e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—melanoma	3.92e-06	6.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—melanoma	3.88e-06	6.23e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—melanoma	3.87e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—melanoma	3.83e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PRKCA—melanoma	3.72e-06	5.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—melanoma	3.71e-06	5.95e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ERCC2—melanoma	3.69e-06	5.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—melanoma	3.68e-06	5.9e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—melanoma	3.6e-06	5.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—melanoma	3.59e-06	5.76e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—melanoma	3.41e-06	5.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—melanoma	3.38e-06	5.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—melanoma	3.38e-06	5.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—melanoma	3.35e-06	5.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—melanoma	3.21e-06	5.15e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—melanoma	3.21e-06	5.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—melanoma	2.95e-06	4.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—melanoma	2.92e-06	4.69e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—melanoma	2.91e-06	4.67e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—melanoma	2.81e-06	4.51e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—melanoma	2.56e-06	4.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—melanoma	2.53e-06	4.07e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—melanoma	2.53e-06	4.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—melanoma	2.26e-06	3.63e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—melanoma	2.23e-06	3.58e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—melanoma	2.21e-06	3.55e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—melanoma	2.08e-06	3.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—melanoma	2.07e-06	3.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—melanoma	2.06e-06	3.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—melanoma	1.93e-06	3.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—melanoma	1.85e-06	2.97e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—melanoma	1.7e-06	2.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—melanoma	1.69e-06	2.7e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—melanoma	1.36e-06	2.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—melanoma	1.11e-06	1.78e-05	CbGpPWpGaD
